Status:
COMPLETED
An Open Study to Investigate the Safety and Efficacy of Replenine®-VF in Severe Haemophilia B Patients
Lead Sponsor:
Bio Products Laboratory
Conditions:
Haemophilia B
Eligibility:
All Genders
12+ years
Phase:
PHASE3
Brief Summary
To compare the first and second recovery assessments on Replenine®-VF and to evaluate recovery of different batches if patients changed batches during the study. To evaluate Replenine®-VF in terms of...
Eligibility Criteria
Inclusion
- Previously treated patients
- At least 12 years of age
- Severe Haemophilia B and without inhibitor to factor IX
Exclusion
- \-
Key Trial Info
Start Date :
July 1 1997
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02231944
Start Date
July 1 1997
Last Update
February 22 2018
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinika Hematologii Instytutu Medycyny Wewnetrznej
Lodz, Poland
2
Klinika Hematologii AM Lublin, ul.Jaczewskiego 8
Lublin, Poland
3
Addenbrooke's Hospital, Hills Road
Cambridge, United Kingdom
4
University Hospital of Wales, Heath Park
Cardiff, United Kingdom